The global biosimilars market, valued at US$22.58 billion in 2024, is projected to reach US$171.79 billion by 2033 at a 25.5% CAGR. Explore drivers like rising FDA approvals (71 as of March 2025), oncology dominance, and expansions into autoimmune and chronic diseases amid cost-saving biologic innovations. https://finance.yahoo.com/news/biosimilars-market-surpass-us-171-141500245.html